GIM
Granahan Investment Management Portfolio holdings
AUM
$2.46B
This Quarter Return
+16.74%
1 Year Return
+66.36%
3 Year Return
+183.04%
5 Year Return
+309.49%
10 Year Return
+1,968.52%
AUM
$2.4B
AUM Growth
+$2.4B
(-5.8%)
Cap. Flow
-$267M
Cap. Flow
% of AUM
-11.17%
Top 10 Holdings %
Top 10 Hldgs %
28.1%
Holding
209
New
22
Increased
54
Reduced
104
Closed
29
Top Buys
| 1 |
MRX
Marex Group
MRX
|
$29.8M |
| 2 |
KLC
KinderCare Learning Companies, Inc.
KLC
|
$25.7M |
| 3 |
Sweetgreen
SG
|
$21.3M |
| 4 |
Archer Aviation
ACHR
|
$20.7M |
| 5 |
Sportradar
SRAD
|
$16.1M |
Top Sells
| 1 |
Axon Enterprise
AXON
|
$43.6M |
| 2 |
Zeta Global
ZETA
|
$39.7M |
| 3 |
SMAR
Smartsheet Inc.
SMAR
|
$33.3M |
| 4 |
Chart Industries
GTLS
|
$30.4M |
| 5 |
Toast
TOST
|
$25.6M |
Sector Composition
| 1 | Technology | 34.89% |
| 2 | Industrials | 16.58% |
| 3 | Healthcare | 15.75% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Financials | 8.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Acadia Healthcare
ACHC
$2.15B
| $5.64M | 0.24% |
142,236
+93,346
| +191% | +$3.7M |
|
|
NPKI
102
NPK International Inc.
NPKI
$871M
| $5.41M | 0.23% |
705,707
+21,816
| +3% | +$167K |
|
103
Descartes Systems
DSGX
$8.54B
| $5.28M | 0.22% |
46,474
-8,639
| -16% | -$981K |
|
104
Revolution Medicines
RVMD
$7.43B
| $5.22M | 0.22% |
119,430
-29,929
| -20% | -$1.31M |
|
105
Arcus Biosciences
RCUS
$1.24B
| $5.15M | 0.22% |
346,093
-11,745
| -3% | -$175K |
|
106
Cellebrite
CLBT
$4.04B
| $5.01M | 0.21% |
227,397
+93,259
| +70% | +$2.05M |
|
107
Stevanato
STVN
$6.36B
| $4.93M | 0.21% |
226,401
+110,418
| +95% | +$2.41M |
|
108
Apellis Pharmaceuticals
APLS
$3.51B
| $4.93M | 0.21% |
154,418
+3,840
| +3% | +$123K |
|
109
McGrath RentCorp
MGRC
$3.01B
| $4.64M | 0.19% |
+41,533
| New | +$4.64M |
|
110
Onto Innovation
ONTO
$5.03B
| $4.45M | 0.19% |
26,704
+2,261
| +9% | +$377K |
|
111
Parsons
PSN
$8.4B
| $4.44M | 0.19% |
48,150
-160,086
| -77% | -$14.8M |
|
112
Allegro MicroSystems
ALGM
$5.52B
| $4.41M | 0.18% |
201,817
-81,458
| -29% | -$1.78M |
|
113
Merus
MRUS
$5.04B
| $4.4M | 0.18% |
104,562
-8,689
| -8% | -$365K |
|
114
Rambus
RMBS
$7.93B
| $4.37M | 0.18% |
82,620
-24,306
| -23% | -$1.28M |
|
115
Euronet Worldwide
EEFT
$3.72B
| $4.36M | 0.18% |
42,412
+9,600
| +29% | +$987K |
|
116
DoubleVerify
DV
$2.61B
| $4.26M | 0.18% |
221,881
+23,149
| +12% | +$445K |
|
117
Apogee Therapeutics
APGE
$2.27B
| $4.21M | 0.18% |
92,854
+1,097
| +1% | +$49.7K |
|
118
RxSight
RXST
$364M
| $4.13M | 0.17% |
120,233
+187
| +0.2% | +$6.43K |
|
119
iRhythm Technologies
IRTC
$5.67B
| $4.12M | 0.17% |
45,730
-26,698
| -37% | -$2.41M |
|
120
Universal Technical Institute
UTI
$1.5B
| $4.08M | 0.17% |
158,859
-11,700
| -7% | -$301K |
|
121
Ciena
CIEN
$13.4B
| $4.02M | 0.17% |
47,458
-30,778
| -39% | -$2.61M |
|
122
Okta
OKTA
$15.8B
| $4.01M | 0.17% |
50,852
+9,823
| +24% | +$774K |
|
123
Nova
NVMI
$7.14B
| $3.95M | 0.17% |
20,068
+2,819
| +16% | +$555K |
|
124
Agios Pharmaceuticals
AGIO
$2.36B
| $3.8M | 0.16% |
115,687
-35,098
| -23% | -$1.15M |
|
125
Novanta
NOVT
$4.05B
| $3.73M | 0.16% |
24,444
-4,302
| -15% | -$657K |
|